2-Acetamido-1,3,4,6-tetra-O-acetyl-2-deoxy-b-D-galactopyranose
CAS: 3006-60-8
Ref. 3D-MA07056
| 1g | 82.00 € | ||
| 2g | 119.00 € | ||
| 5g | 198.00 € | ||
| 10g | 274.00 € | ||
| 25g | 419.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
Product Information
Name:
2-Acetamido-1,3,4,6-tetra-O-acetyl-2-deoxy-b-D-galactopyranose
Synonyms:
- b-D-Galactosamine pentaacetate
- (2S,3R,4R,5R,6R)-3-Acetamido-6-(acetoxymethyl)tetrahydro-2H-pyran-2,4,5-triyl triacetate
- 2-Acetamido-1,3,4,6-Tetra-O-Acetyl-2-Deoxy-B-D-Galactopyranose
- 2-Acetamido-1,3,4,6-tetra-O-acetyl-2-deoxy-beta-D-galactopyranose
- 2-Acetamido-1,3,4,6-tetrakis-(O-acetyl)-2-deoxy-<span class="text-smallcaps">D</span>-galactospyranose
- Galactopyranose, 2-acetamido-2-deoxy-, 1,3,4,6-tetraacetate, β-<span class="text-smallcaps">D</span>-
- beta-D-Galactosamine pentaacetate
- beta-D-galactopyranose, 2-(acetylamino)-2-deoxy-, 1,3,4,6-tetraacetate
- β-<span class="text-smallcaps">D</span>-Galactopyranose, 2-(acetylamino)-2-deoxy-, 1,3,4,6-tetraacetate
CAS:
Description:
2-Acetamido-1,3,4,6-tetra-O-acetyl-2-deoxy-b-D-galactopyranose is fully acetylated D-galactosamine (C4 epimer of D-glucosamine). 2-Acetamido-1,3,4,6-tetra-O-acetyl-2-deoxy-b-D-galactopyranose is used in the synthesis of α- and β-linked acetamido pyranosides, which have anti-inflammatory properties as inhibitors of TLR4.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
389.35 g/mol
Formula:
C16H23NO10
Purity:
Min. 95%
Color/Form:
Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 3D-MA07056 2-Acetamido-1,3,4,6-tetra-O-acetyl-2-deoxy-b-D-galactopyranose
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
